VIVS insider trading
NasdaqCM HealthcareVivoSim Labs, INC.: insider trade history from SEC Form 4 filings.
About VivoSim Labs, INC.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Company website: vivosim.ai
VIVS insider activity at a glance
FilingIQ tracks 7 insider transactions for VIVS in filings since Nov 19, 2025. The most recent transaction is dated Aug 31, 2026.
Across the full history, 1 open-market purchases
and 1 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest VIVS Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VIVS?
- FilingIQ tracks 7 Form 4 insider transactions for VIVS (VivoSim Labs, INC.), covering filings from Nov 19, 2025 onwards. 1 of those are dated within the last 90 days.
- Are VIVS insiders net buyers or net sellers?
- Across the full Form 4 history for VIVS, 1 transactions (14%) were open-market purchases and 1 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VIVS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is VIVS in?
- VivoSim Labs, INC. (VIVS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.41M.
Methodology & sources
Every VIVS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.